SRx Health Solutions Inc. 2026年季度报告

FORM 10-Q Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes☐No☒ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller Large accelerated filer☐Accelerated filer☐Non-accelerated filer☒Smaller reportingcompany If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ The number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date was:298,207,684 shares of $0.001 par value common stock outstanding as of February 11, 2026. 1.Unaudited Condensed Consolidated Financial Statements 3.Quantitative and Qualitative Disclosures About Market Risk364.Controls and Procedures36Part II Table of Contents FORWARD-LOOKING STATEMENTS This report contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements ofhistorical fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations andprojections relating to our financial condition, results of operations, plans, objectives, future performance and business. You canidentify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements mayinclude words such as “aim,” “anticipate,” “believe,” “can,” “could,” “estimate,” “expect,” “forecast,” “intend,” “likely,” “may,”“outlook,” “plan,” “potential,” “project,” “projection,” “seek,” “should,” “will,” “would,” the negatives thereof and other words andterms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or ●the impact of damage to or interruption of our information technology systems due to cyber-attacks or other circumstances beyondour control; ●business interruptions resulting from geopolitical actions, including war and terrorism; ●our ability to successfully implement our growth strategy; ●failure to achieve growth or manage anticipated growth; ●our ability to achieve or maintain profitability; ●the loss of key members of our senior management team; ●our ability to generate sufficient cash flow or raise capital on acceptable terms to run our operations, service our debt and makenecessary capital expenditures; ●our dependence on our subsidiaries for payments, advances and transfers of funds due to our holding company status; ●our ability to successfully develop additional products and services or successfully market and commercialize such products andservices; ●competition in our market; ●our ability to attract new and retain existing customers, suppliers, distributors or retail partners; ●allegations that our products cause injury or illness or fail to comply with government regulations; ●our ability to manage our supply chain effectively; ●our or our co-manufacturers’ and suppliers’ ability to comply with legal and regulatory requirements; ●the effect of potential price increases and shortages on the inputs, commodities and ingredients that we require, whether as a resultof the continued actual or perceived effects of broader geopolitical and macroeconomic conditions, including the military conflictbetween Russia and Ukraine; Table of Contents ●our ability to develop and maintain our brand and brand reputation; ●compliance with data privacy rules; ●our compliance with applicable regulations is